<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03588624</url>
  </required_header>
  <id_info>
    <org_study_id>06001</org_study_id>
    <nct_id>NCT03588624</nct_id>
  </id_info>
  <brief_title>Study of the TearCare System in Dry Eye Disease</brief_title>
  <official_title>Study of the TearCare System in Dry Eye Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sight Sciences, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sight Sciences, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to evaluate the short-term (1 month) safety and effectiveness
      of a single TearCare procedure to treat adult patients with dry eye disease.

      NOTE: All sites have been selected for this study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 12, 2018</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Tear Break-up time from baseline to 1 month</measure>
    <time_frame>1 month</time_frame>
    <description>Tear Break-up Time is defined as the number of seconds between a blink and the appearance of a first dry spot or negative staining in the tear film.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Ocular Surface Disease Index (OSDI) score from baseline to 1 month</measure>
    <time_frame>1 month</time_frame>
    <description>The OSDI is a questionnaire that assesses the symptoms of dry eye disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Meibomian gland secretion score from baseline to 1 month</measure>
    <time_frame>1 month</time_frame>
    <description>The is a measure of the quality of the secretions from the meibomian glands</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cornea staining score from baseline to 1 month</measure>
    <time_frame>1 month</time_frame>
    <description>This is a measure of the degree of staining on the cornea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Conjunctival staining score from baseline to 1 month</measure>
    <time_frame>1 month</time_frame>
    <description>This is a measure of the degree of staining on the conjunctiva</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device-related adverse events</measure>
    <time_frame>1 month</time_frame>
    <description>Any untoward adverse event that is attributed to the study device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in best spectacle-corrected visual acuity from baseline to 1 month</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>TearCare</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects in the study will undergo the TearCare procedure one time at the baseline visit. They will then be followed out to one month.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TearCare</intervention_name>
    <description>The TearCare procedure includes the delivery of thermal energy to the external surface of the eyelids for 15 minutes, immediately followed by manual expression of each eyelid.</description>
    <arm_group_label>TearCare</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with dry eye disease

          -  Signs and symptoms of dry eye disease

          -  Best corrected visual acuity 20/100 or better

          -  Willing and able to comply with study procedures

          -  Willing and able to provide consent

        Exclusion Criteria:

          -  Active ocular infection or inflammation

          -  History of eyelid, conjunctiva or corneal surgery within the past year.

          -  Recent office-based dry eye treatment, punctal occlusion or punctal plug placement

          -  Contact lens wearer

          -  Significant ocular surface or eyelid abnormalities, recent ocular trauma

          -  Certain corneal surface abnormalities

          -  Use of medications for treatment of dry eye or medications that cause dry eye

          -  Systemic disease that results in dry eye
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anne Ripley</last_name>
    <phone>6616458546</phone>
    <email>anne@sightsciences.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eye Research Institute</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yvette Abbascia</last_name>
      <phone>949-650-1863</phone>
      <email>yvette.abbascia@drwirta.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kentucky Eye Institute</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40517</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Tincher</last_name>
      <email>justin.tincher@kyeye.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>July 3, 2018</study_first_submitted>
  <study_first_submitted_qc>July 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2018</study_first_posted>
  <last_update_submitted>August 15, 2018</last_update_submitted>
  <last_update_submitted_qc>August 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

